05.01.23
The Beauty Health Company, home to flagship brand Hydrafacial, marks the second anniversary of its public listing by ringing the Opening Bell of the NASDAQ exchange.
The BeautyHealth Executive Committee and senior leaders, as well as members of Hydrafacial’s dedicated community of providers, will gather at NASDAQ’s New York City MarketSite in Times Square to commemorate the milestone.
"We have so much to be proud of since Beauty Health was formed in 2021. In just two years as a public company, we have launched our biggest innovation, Syndeo, and taken it international; upgraded our global infrastructure to fuel long-term profitable growth; partnered with some of the best skincare brands in the business; and begun to add new offerings to our portfolio,” said BeautyHealth President and CEO Andrew Stanleick. “While we are just getting started in many ways, our legacy of innovation began more than 25 years ago with the first hydradermabrasion device and a budding community of skin enthusiasts. Sixty patents, 90 countries and more than 40,000 estheticians later, we have created a category of beauty and health treatments that are revolutionizing the way we all think about skin health. Our vision is to become the world’s leading beauty health and wellness platform, fueled by a community of engaged providers, estheticians and consumers.”
Hydrafacial created the category of hydradermabrasion in 1997. Since then, consumers worldwide have come to rely on the enjoyable and efficacious treatment and a boost in self-confidence. More than two decades and tens of millions of skin health experiences later, parent company BeautyHealth is meaningfully advancing its strategic plan. With the recent acquisition of microneedling device SkinStylus and continued growth of Hydrafacial and scalp health treatment Keravive, BeautyHealth is maturing into the multi-brand ecosystem that was envisioned at its inception.
Under the ticker symbol SKIN, BeautyHealth was first listed on the NASDAQ in 2021 upon the completion of the Hydrafacial and Vesper Healthcare business combination. Since its debut to the public markets, BeautyHealth has delivered consistent double-digit top-line growth while investing in its business, including +41% net sales growth in FY22, its first full year traded.
In the company’s two-year history, BeautyHealth has more than doubled the size of the business, growing top-line sales by 120% on a full-year basis; expanded Hydrafacial’s install base around the world +66%; launching Hydrafacial Syndeo, connected device in the US and across key European and Asia-Pacific markets; built a portfolio of marquee, co-created boosters through partnerships with the best in skincare including Dior Beauty, Omorovicza, JLO Beauty, Alastin, Babor, Dr. Dennis Gross, Murad and others; expanded Hydrafacial Experience Centers, key touch points for estheticians, influencers and media, in more than a dozen global cities including New York City, Paris, Singapore and Beijing; trained more than 40,000 estheticians globally through the premier HFX education program; scaled Hydrafacial’s omni-channel availability, including its presence throughout all Sephora US doors and its Singapore “Store of the Future,” as well as joining the signature wellness floor at Galeries Lafayette Haussmann in Paris; grew Hydrafacial awareness, trial and affinity, with earned media value and Google Search trends up 166% and 39%, respectively, since 2019; and acquired SkinStylus, an FDA-cleared microneedling device and one of the most complementary co-treatments to Hydrafacial.